Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 2, 1998, Pages 188-196

  Gouyer, Valérie ^a   Gazzéri, Sylvie ^a   Bolon, Isabelle ^a   Drevet, Christiane ^a   Brambilla, Christian ^a   Brambilla, Elisabeth ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; RETINOBLASTOMA PROTEIN; RNA;

ARTICLE; CARCINOMA; CHEMISTRY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; NEUROENDOCRINE TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CARCINOMA; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RETINOBLASTOMA; HUMANS; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0031991525     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.2.3008     Document Type: Article

References (55)

1. Arrigoni, M. G., L. B. Woolner, and P. E. Bernalz. 1972. Atypical carcinoid tumors of the lung. J. Thorac. Cardiovasc. Surg. 44:413-421.
2. Travis, W. D., R. I. Linnoila, M. G. Tsokos, C. L. Hitchcock, G. B. Culler, L. Nieman, G. Chrousos, H. Pass, and J. Doppman. 1991. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinomas. Am. J. Surg. Pathol. 15:529-533.
3. Minna, J. D. 1993. The molecular biology of lung cancer pathogenesis. Chest 103:449S-456S.
4. Harbour, J. W., S. L. Lai, J. Whang-Peng, A. F. Gazdar, J. D. Minna, and F. J. Kaye. 1988. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353-357.
5. Shimizu, E., A. Coxon, G. A. Olterson, S. M. Steinberg, R. A. Kratzke, Y. Kim, J. Fedorko, H. Oie, B. E. Johnson, J. L. Mulshine, J. D. Minna, A. F. Gazdar, and F. J. Kaye. 1994. RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 9:2441-2448.
6. Weintraub, S. J. 1996. Inactivation of tumor suppressor proteins in lung cancer. Am. J. Respir. Cell Mol. Biol. 15:150-155.
7. Friend, S. H., J. M. Horowitz, M. R. Gerber, X. F. Wang, E. Begenmann, F. P. Li, and R. A. Weinberg. 1987. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein, Proc. Natl. Acad. Sci. USA 84:9089-9063.
8. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinublastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58: 1097-1105.
9. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
10. Resnitzky, D., and S. I. Reed. 1995. Different roles of cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
11. Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (London) 366: 707-710.
12. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, O. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day III, B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumors types. Science 264:436-440.
13. DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. H. Huang, W.-H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
14. Whyte, P., N. M. Williamson, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124-129.
15. Dyson, N., P. M. Howley, K. Münger, and E. Harlow. 1989. The papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
16. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
17. Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1A prevents the relinoblastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494-497.
18. Rustgi, A., N. Dyson, and R. Bernards. 1991. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (London) 352:541-544.
19. Hu. Q., N. Dyson, and E. Harlow. 1990. Regions of relinoblastoma protein needed for the binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147-1155.
20. Kaelin, W. G., M. E. Ewen, and D. M. Livingston. 1991. Definition of the minimal simian virus SV40 large T antigen- and adenovirus E1A-binding domain in the retinoblasloma gene product. Mol. Cell. Biol. 10:3761-3769.
21. Mudryj, M., S. W. Hiebert, and J. R. Nevins. 1990. A role of adenovirus inductible E2F transcription factor in a proliferation dependent signal pathway. EMBO J. 9:2179-2184.
22. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Relinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (London) 375:503-506.
23. Mokotura, T., and A. Arnold. 1993. Cyclins and oncogenesis. Biochim. Biophys. Acta 1155:63-78.
24. Horowitz, J. M., S.-H. Park, E. Bogemann, J.-C. Cheng, D. W. Yandell, F. J. Kaye, J. D. Minna, T. P. Dryja, and R. A. Weinberg. 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87:2775-2779.
25. Clarke, A. R., E. R. Maandag, M. Van Roon, N. M. T. Van der Lugt, M. Van der Valk, M. L. Hooper, A. Berns, and H. Te Riele. 1992. Requirement for a functional Rb-1 nene in murine development. Nature (London) 359:328-330.
26. Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haemotopoiesis. Nature (London) 359: 288-294.
27. Jacks, T., A. Fazelli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse.Nature (London) 259:295-300.
28. Lovejoy, E. A., A. R. Clarke, and D. J. Harrison. 1997. Animal models and the molecular pathology of cancer. J. Pathol. 181:130-135.
29. Harvey, M., H. Vogel, E. Y.-H. P. Lee, A. Bradley, and L. A. Donehower. 1995. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 55:1146-1151.
30. Hensel, C. H., C. L. Hsieh, A. F. Gazdar, B. F. Johnson, A. Y. Sakaguchi, S. Naylor, W. H. Lee, and F. Y.-H. P. Lee. 1990. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 50:1067-1072.
31. Cagle, P. T., A. K. El-Naggar, H. J. Xu, S. X. Hu, and W. F. Benedict. 1997. Differential retinohlastoma protein expression in neuroendocrine tumors of the lung. Am. J. Pathol 150:393-400.
32. Yokota, J., T. Akiyama, Y.-K. T. Fung, W. F. Benedict, Y. Namba, M. Hanaoka, M. Wada, T. Terasaki, Y. Shimosato, T. Sugimura, and M. Terada. 1988. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3:471-175.
33. Yokota, J., M. Wada, Y. Shimosato, M. Terada, and T. Sugimura. 1987. Loss of heterozygosity on chromosomes 3, 13 and 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 84:9252-9556.
34. INK4 expression in resected non-small cell lung tumors. Cancer Res. 56:3415-3420.
35. Betticher, D. C., J. Heighway, P. S. Hasleton, H. J. Altermatl, W. Ryder, T. Cerny, and N. Thatcher. 1996. Pronostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer 73:294-300.
36. Gouyer, V., S. Gazzeri, F. Brambilla, I. Bolon, D. Moro, P. Perron, A. L. Benabid, and C. Bramhilla. 1994. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinomas. Int. J. Cancer 58:818-824.
37. Brambilla, E., D. Veale, D. Moro, F. Morel, F. Dubois, and C. Brambilla. 1992. Neuroendocrine phenotype in lung cancers. Am. J. Clin. Pathol. 98: 88-97.
38. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
39. Friend, S. H., R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja. 1986. A human DNA segment with properties ot the gene that predisposes to retinoblastoma and osteosarcoma. Nature (London) 323:643-646.
40. Greger, V., N. Debus, D. Lohman, W. Hôpping, F. Passarge, and B. Horsthemke. 1994. Frequency and parental origin nf hypermethylated RB1 alleles in retinoblastoma. Hum. Genet. 94:491-496.
41. Hogg, A., Z. Onadim, P. N. Baird, and J. K. Cowell. 1992. Detection of hetcrozygous mutations in the RB1 gene in retinoblasloma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. Oncogene 7:1444-1451.
42. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
43. Ryggard, K . D. Sorenson, O. S. Petengill, C. C. Cate, and M. Spang-Thomsen. 1990. Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice. Cancer Res. 50:5312-5317.
44. Kaye, F. J., R. A. Kratzke, J. L. Gerster, and J. M. Horowitz. 1990. A single amino acid substitution results in a retinoblastoma protein detective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87:6922-6426.
45. Shew, J. Y., B. T.-Y. Lin, P.-L. Chen, B. Y. Tseng, T. L. Yang-Feng, and W. H. Lee. 1990. C-terminal truncation of the retinoblasloma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. USA 87:6-10.
46. Mori, N., J. Yokota, T. Akiyama, Y. Sameshima, A. Okamoto, H. Mizoguchi, K. Toyoshima, T. Sugimura, and M. Terada. 1990. Variable mutations oi the RB gene in small-cell lung carcinoma. Oncogene 5:1713-1717.
47. Yandell, D. W., T. A. Campbell, S. H. Dayton, R. Peterseb, D. Walton, J. B. Little, A. McConkie-Rosell, E. G. Buckley, and T. P. Dryja. 1989. Oncogenic point mutations in human retinoblastoma gene: their application to genetic counseling. N. Engl. J. Med. 321:1689-1698.
48. Hogg, A., B. Bia, Z. Onadim, and J. K. Cowell. 1993. Molecular mechanism of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc. Natl. Acad. Sci. USA 90:7351-7355.
49. Merlo, A., J. G. Herman, L. Mao, D. J. Lee, F. Gabrielson, P. C. Burger, S. B. Baylin, and D. Sidransky. 1945. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/ MTS1 in human cancers. Nature Med. 1:686-692.
50. Murakami, Y., M. Kalahira, R. Makino, K. Hayashi, S. Hirohashi, and T. Sekiya. 1991. Inactivation of the retinoblasloma gene in a human lung carcinoma cell line detected by single-strand conformation polymorphism analysis of the polymerase chain reaction product of cDNA. Oncogene 6:37-42.
51. Sachse, R., Y. Murakami, M. Shiraishi, K. Hayashi, and T. Sekiya. 1994. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Oncogene 9:34-47.
52. Hensey, C. E., F. Hong, T. Durfee, Y. W. Qian, F. H. P. Lee, and W. H. Lee. 1994. Identification of discrete structural domains in the retinoblastoma protein. J. Biol. Chem. 269:1380-1387.
53. Sterner, J. M., Y. Tao, S. B. Kennett, H. G. Kim, and J. M. Horowitz. 1996. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependant kinase-like kinase via Rb amino acids required for growth suppression. Cell Growth Differ. 7:53-64.
54. Gerdes, J., V. Schawb, H. Lemke, and H. Stein. 1983. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 32:13-20.
55. Ookawa, K., M. Shiseki, R. Takahashi, Y. Yoshida, M. Terada, and J. Yokota. 1993. Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene 8:2175-2181.